Exchange: NASDAQ·Updated 04:08 AM EDT
News
all
press releases
Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 160.1% in Ascentage Pharma Group International - Unsponsored ADR (AAPG). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks
More News
How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23%
The consensus price target hints at a 152.2% upside potential for Ascentage Pharma Group International - Unsponsored ADR (AAPG). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Time to Sell?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next...
MarketBeat
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Down 51.1% in April
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short...
MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Large Volume Increase - Here's Why
Ascentage Pharma Group International (NASDAQ:AAPG) Sees Unusually-High Trading Volume - Should You Buy...
MarketBeat
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Receives Consensus Recommendation of "Buy" from Analysts
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) has received an average rating of "Buy" from the seven brokerages that are presently covering the stock...
MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Down 8.4% - What's Next?
Ascentage Pharma Group International (NASDAQ:AAPG) Trading Down 8.4% - What's Next...
MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - What's Next?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Down - Here's Why...
MarketBeat
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG) Short Interest Update
Ascentage Pharma Group International - Unsponsored ADR (NASDAQ:AAPG - Get Free Report) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totaling 1,470 shares, an increase of 54.6% from the March 15th total of 951 shares...
MarketBeat
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Should You Buy?
Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up - Still a Buy...
MarketBeat

Advertisement|Remove ads.